Merck Confirms Its Commitment to Korea

뉴스 제공

Merck Ltd.

2008-05-09 14:36

Seoul--(뉴스와이어)--Merck in Korea, a Korean subsidiary of Merck KGaA of Darmstadt, Germany, announced today that an executive board member of the parent company, Dr. Bernd Reckmann, is visiting Korea in his new capacity as the first chairman of the German Korean Business Association.

Dr. Reckmann, who is responsible for Merck’s global Chemicals business sector, plans meetings on May 12 with Investment Ombudsman, the Ministry of Knowledge Economy and the Korea German Chamber of Commerce & Industry. Dr. Reckmann was President of Merck in Korea prior to his promotion to the Merck Executive Board in January 2007.

His visit reinforces Merck’s commitment to Korea and the Korean display industry. Merck, the world’s largest producer of liquid crystals, announced earlier this year that it will invest 14 billion Korean Won (EUR 11 million) to establish an Advanced Technology Center (ATC) in Korea to improve Merck’s R&D and manufacturing capacities. The investment is intended to strengthen Merck’s position as market and technology leader for liquid crystals materials.

Merck in Korea was founded in 1989 and expanded its business by establishing Merck Advanced Technologies Ltd. (MAT) in 2002 to consolidate all its display activities and to better serve the Korean display industry.

”Close cooperation with our customers is a key to our successful business development here in Korea,” said Dr. Reckmann. “Merck remains committed to providing innovative solutions to ensure the future success of our customers and the Korean display industry.”

Merck’s cutting-edge technologies are not limited to liquid crystals but also include OLED (Organic Light-Emitting Diodes), Organic Electronics, Structuring Solutions and Reactive Mesogen.

About Merck in Korea:

Merck Ltd., registered in 1989, and Merck Advanced Technologies Ltd., established in 2002, are the Merck companies in Korea and operate in pharmaceuticals and the chemical industries of Liquid Crystals, Performance & Life Science Chemicals such as Pigments, Life Science products and Analytics. In 1999, Merck in Korea set up its Korean pharmaceutical operation. This was integrated with Serono Korea after Merck KGaA’s purchase of Serono S.A. in 2007.

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merck.co.kr .

Merck is a global pharmaceutical and chemical company with sales of EUR 7.1 billion in 2007, a history that began in 1668, and a future shaped by 30,962 employees in 61 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

웹사이트: http://www.merck.co.kr